Article

A single oral immunization with a replication-competent adenovirus-vectored vaccine protects mice from influenza respiratory infection

2021-07-21

Abstract excerpt

The development of effective and flexible vaccine platforms is a major public health challenge as recently highlighted by the COVID-19 pandemic. Adenoviruses (AdVs) are easy to produce and have a good safety and efficacy profile when administered orally as demonstrated by the long-term use of oral AdV 4 and 7 vaccines in the US military. These viruses therefore appear to be the ideal backbone for the development o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 823b13b9-9202-59af-87bc-380a5e9aabbf
DOI: 10.1101/2021.07.21.453241

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A single oral immunization with a replication-competent adenovirus-vectored vaccine protects mice from influenza respiratory infectionDOI 10.1101/2021.07.21.453241Read

A novel intranasal administration adenoviral vector-based platform for rapid COVID-19 vaccine developmentSemantic proximity Read

Intranasal HD-Ad Vaccine Protects the Upper and Lower Respiratory Tracts of hACE2 Mice against SARS-CoV-2Semantic proximity Read

Production of adenovirus vectors and their use as a delivery system for influenza vaccinesSemantic proximity Read

Transgene Expression Kinetics and Replication Potential of Recombinant Adenovirus Serotype 4 in a Mouse Model and its Use as a Herpes Simplex Virus VaccineSemantic proximity Read

Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 HemagglutininSemantic proximity Read

Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2Semantic proximity Read

Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A AntigensSemantic proximity Read

Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine ResponsesSemantic proximity Read

Pros and Cons of Adenovirus-Based SARS-CoV-2 VaccinesSemantic proximity Read

Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse modelSemantic proximity Read

Adenovirus Vector-Based Vaccines for Human Immunodeficiency Virus Type 1Semantic proximity Read

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunizationSemantic proximity Read